ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Activity

8 hedge funds and large institutions have $188K invested in Oramed Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
8
Holders Change
+8
Holders Change %
–
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CS
1
Credit Suisse
Switzerland
$125K
2
FNBT
2
FineMark National Bank & Trust
Florida
$28K
3
Wells Fargo
3
Wells Fargo
California
$11K
4
TRCT
4
Tower Research Capital (TRC)
New York
$9K
5
MA
5
MUFG Americas
New York
$7K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
CS
1
Credit Suisse
Switzerland
$125K 15,272 +15,272 New
FNBT
2
FineMark National Bank & Trust
Florida
$28K 3,473 +3,473 New
Wells Fargo
3
Wells Fargo
California
$11K 1,358 +1,358 New
TRCT
4
Tower Research Capital (TRC)
New York
$9K 1,100 +1,100 New
MA
5
MUFG Americas
New York
$7K 834 +834 New
HRIA
6
Haberer Registered Investment Advisor
Ohio
$3K 334 +334 New
U
7
UBS
Switzerland
$3K 417 +417 New
Royal Bank of Canada
8
Royal Bank of Canada
Ontario, Canada
$2K 200 +200 New